Tuesday, Sep 16, 2025 · SEC filings
What the smart money revealed on Sep 16
460 insider filings came in. We hid 99 planned (10b5-1) sellers and 221 people whose filings were routine, like grants and tax withholding.
Lb Pharmaceuticals (LBRX) Director Ran Nussbaum bought $15M
1M shares on the open market. Not a grant or an option exercise.
NextDecade (NEXT) Director William Vrattos bought $3.65M
500,000 shares on the open market. Not a grant or an option exercise.
Strategy (MSTR) EVP & General Counsel Wei-Ming Shao bought $1.21M
12,500 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
NGL Energy Partners (NGL) Director James Collingsworth bought $580K
100,000 shares on the open market. Not a grant or an option exercise.
Robinhood Markets (HOOD) CEO Vladimir Tenev sold $404M
Not marked as a planned 10b5-1 sale. Sold 51% of the shares they held directly. Still holds 3.39M shares.
Waystar Holding (WAY) Director Paul Moskowitz sold $168M
Not marked as a planned 10b5-1 sale. Sold 24% of the shares they held directly. Still holds 13.76M shares.
EchoStar CORP (SATS) COO Paul Gaske sold $778K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 32 more real buys
Show 74 more real sales
13F season
Holdings as of Jun 30, 2025 were due Aug 14
74 funds have filed. 68 filed for the quarter before.
Biggest real insider buys, Sep 10–16
Open-market buys by officers and directors, filed in the 7 days up to Sep 16.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.